Hikma appoints new President of Injectables business
LONDON, UK: Hikma Pharmaceuticals PLC and its subsidiaries announcd that Dr. Bill Larkins has been appointed President of its Injectables business, effective 1 September 2023....
Hikma Launches New 503B Sterile Compounding Business
LONDON, UK: Hikma Pharmaceuticals, the multinational pharmaceutical company, announced the launch of Hikma 503B – a new outsourced sterile compounding business focused on providing high...